ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury MARLBOROUGH, MA, BERLIN, Germany,[...]
R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype MARLBOROUGH, Mass. and BERLIN and YOKNEAM[...]
Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons. MARLBOROUGH, MA,[...]
MARLBOROUGH, MA, BERLIN, Germany and YOKNEAM ILLIT, Israel, November 6, 2023 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a[...]
2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons.
Recently ReWalk Robotics™ announced the acquisition of AlterG® Inc., a global industry leader in innovative rehabilitation technology and the makers of the[...]
Combined Company Expands Patient and Clinician Access to Innovative Rehabilitation Technologies for Home and Clinic Use Transaction Projected to Increase Revenue Growth[...]
ReWalk Robotics Applauds Medicare Proposal to Include Personal Exoskeletons in a Medicare Benefit Category to be Paid on a Lump Sum Basis[...]
Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs Paralyzed individuals with spinal[...]
